Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3 H-benzimidazole-5-carboxamide
2. Fk614 Cpd
1. Fk-614
2. 193012-35-0
3. Fk614
4. Atx08-001
5. V5q32bzx79
6. 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxamide
7. Unii-v5q32bzx79
8. Fk 614
9. Schembl682052
10. Chembl3545278
11. Dtxsid60940978
12. Bdbm50469398
13. Db12557
14. Sb16865
15. 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3 H-benzimidazole-5-carboxamide
16. 1-[(2,4-dichlorophenyl)methyl]-2-methyl-n-(pentane-1-sulfonyl)-1h-benzimidazole-6-carboximidic Acid
17. Hy-101292
18. Cs-0021092
19. A857643
20. Q27291562
21. 1-(2,4-dichlorobenzyl)-2-methyl-6-(1-pentanesulfonylcarbamoyl)benzimidazole
22. 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxami-de
23. 3-[(2,4-dichlorophenyl)methyl]-2-methyl-n-pentylsulfonylbenzimidazole-5-carboxamide
| Molecular Weight | 468.4 g/mol |
|---|---|
| Molecular Formula | C21H23Cl2N3O3S |
| XLogP3 | 5.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 8 |
| Exact Mass | 467.0837182 g/mol |
| Monoisotopic Mass | 467.0837182 g/mol |
| Topological Polar Surface Area | 89.4 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 688 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Fk 614 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fk 614, including repackagers and relabelers. The FDA regulates Fk 614 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fk 614 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Fk 614 supplier is an individual or a company that provides Fk 614 active pharmaceutical ingredient (API) or Fk 614 finished formulations upon request. The Fk 614 suppliers may include Fk 614 API manufacturers, exporters, distributors and traders.
click here to find a list of Fk 614 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fk 614 DMF (Drug Master File) is a document detailing the whole manufacturing process of Fk 614 active pharmaceutical ingredient (API) in detail. Different forms of Fk 614 DMFs exist exist since differing nations have different regulations, such as Fk 614 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fk 614 DMF submitted to regulatory agencies in the US is known as a USDMF. Fk 614 USDMF includes data on Fk 614's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fk 614 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Fk 614 suppliers with USDMF on PharmaCompass.
Fk 614 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fk 614 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fk 614 GMP manufacturer or Fk 614 GMP API supplier for your needs.
A Fk 614 CoA (Certificate of Analysis) is a formal document that attests to Fk 614's compliance with Fk 614 specifications and serves as a tool for batch-level quality control.
Fk 614 CoA mostly includes findings from lab analyses of a specific batch. For each Fk 614 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fk 614 may be tested according to a variety of international standards, such as European Pharmacopoeia (Fk 614 EP), Fk 614 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fk 614 USP).
LOOKING FOR A SUPPLIER?
